Brief: NeuBase Therapeutics Received Letter From The Nasdaq Stock Market Notifying Notice Of Delisting
03/10/2022 13:52
Oct 3 (Reuters) - NeuBase Therapeutics Inc NBSE.O :
* NEUBASE THERAPEUTICS - ON SEPT 29, RECEIVED LETTER FROM
THE
NASDAQ STOCK MARKET NOTIFYING NOTICE OF DELISTING
Further company coverage: NBSE.O
((Reuters.Briefs@thomsonreuters.com;;))
Recent news on NeuBase Therapeutics
See all newsBrief: Neubase Therapeutics, On May 2, Was Notified By Nasdaq On Not Regained Compliance With Minimum Bid Price Requirement
Brief: Neubase Therapeutics Announces Receipt Of Notice From Nasdaq
U.S. STOCKS ON THE MOVE-TPG, R1 RCM, Zoom
U.S. STOCKS ON THE MOVE-Micron, Krystal Biotech, Pilgrim's Pride
U.S. STOCKS ON THE MOVE-Domino's Pizza, Voyager, Freshpet